Results 191 to 200 of about 6,504,648 (250)

Ex-ante determinants of IPOs: A dataset for the Malaysian IPOs. [PDF]

open access: yesData Brief
Albada A   +4 more
europepmc   +1 more source

Subjective Cognitive Concerns and Cognitive Trajectories in Parkinson's Disease: Biomarker Impact

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the relationship of subjective cognitive concerns (SCC) with biomarkers of Alzheimer's disease (AD), neurodegeneration, and Parkinson's disease (PD) and domain‐specific cognitive trajectories among cognitively unimpaired persons with de novo PD. Method Cognitively unimpaired participants with SCC (n = 294) and without SCC (
Francesca V. Lopez   +5 more
wiley   +1 more source

Neighborhood disorder and ovarian cancer survival in Black women. [PDF]

open access: yesAm J Epidemiol
Pierson C   +17 more
europepmc   +1 more source

Early Clinical and Cerebrospinal Fluid Predictors of 1‐Year Recurrence in Autoimmune GFAP Astrocytopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A) is an inflammatory central nervous system disorder with variable outcomes. Relapse occurs in a subset of patients, but early predictors remain unclear. We aimed to identify admission‐available features associated with 1‐year recurrence and develop an interpretable ...
Qingting Hong   +10 more
wiley   +1 more source

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source

Overcoming data challenges through enriched validation and targeted sampling to measure whole-person health in electronic health records. [PDF]

open access: yesJ Biomed Inform
Lotspeich SC   +9 more
europepmc   +1 more source

Factors Associated With MOG‐IgG Serostatus Change

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Neurologists often re‐test MOG‐IgG, but the frequency and factors associated with serostatus change are unknown. We examined this issue in a clinical cohort of patients serially tested for MOG‐IgG at Cleveland Clinic between 2017 and 2025. Kaplan–Meier curves estimated seroconversion/seroreversion‐free probability.
Katherine Havard‐Coiro   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy